The author modified the first antibody (clone ML00P01) against human PSA onto a nano-structured gold electrode and prepared a conjugate containing the second PSA antibody (clone ML00P02) and survivin ASODN (a sequence complementary with surviving mRNA in cancer cells). This evidence concerns the gene KLK3 and cancer.